Developmental Activities:

Non-Human Clinical Studies

  • cGMP fill and finish operations for pre-filled syringes and auto-injector systems
  • Chemistry and Manufacturing Control (CMC) sections of a Drug Application
  • Identification and qualification of suppliers of device components and assemblies
  • drug solution excipients and active pharmaceutical ingredients (API)
  • Formulation development
  • Container closure system manufacturers in the selection of drug contact materials
  • ICH shelf-life studies
  • Assay method and specifications for API, excipients and final drug product
  • Identification of drug impurities
  • Toxicology studies per FDA Guidelines

MSA News

Dr. Kenneth Dretchen PhD has been appointed as a member of the Pharmaceutical Research and Manufacturers of America (PhRMA) Drug Discovery Research Award Committee.

May 22, 2020 This committee review grant applications for Pre-doctoral, Post-doctoral and Research Starter Grants dealing with innovative approaches that…

Read More

Mesa Science Associates and Bryn Pharma Publish Second Pre-Clinical Study of a New Approach to Treating Anaphylaxis

The second in a series of three studies measured the pharmacokinetic and heart rate effects of intranasal epinephrine in dogs….

Read More

Mesa Science Associates and Bryn Pharma Publish Pre-Clinical Study of a New Approach to Treating Anaphylaxis

April 13, 2020 Mesa Science Associates Inc. (MSA) and Bryn Pharma LLC published the findings from the first of three…

Read More